Subscribe
Machinery & Materials
Markets
Logistics & Cold Chain
Issues
Events
Downloads
FDA
More from FDA
Pharmaceutical
FDA Approves HIV Drug, But Only for Men
Gilead Sciences only tested Descovy on men and transgender women, and the approval explicitly excludes cisgender women.
Pharmaceutical
FDA and DEA Target More Illegal Opioid Websites
In the continued fight against the opioid crisis, the FDA and DEA issued joint warning letters to websites illegally marketing and selling opioids.
Home
CDC and FDA Continue to Investigate Lung Illness Outbreak
Consumers are urged to avoid products containing tetrahydrocannabinol while the investigations continue to move forward.
Regulatory
FDA: Don’t Drink Bleach to Cure Cancer or Autism
The FDA is warning people not to drink “Miracle Mineral Solution,” as it’s the same as drinking bleach and extremely dangerous.
Regulatory
FDA Demands 44 Vape Pods Cease Sales
The FDA continues its attack on vaping by telling manufacturers of dozens of vape pod and hookah products to stop selling items immediately.
Medical device packaging
The FDA Wants a Virtual Heart to Test Medical Devices
The FDA is seeking computational software that models the human heart to test medical devices and therapies.
Regulatory
FDA Science Forum: Sep. 11 and 12
Topics covered at ‘Transforming Health: Innovation in FDA Science’ will include labels, digital health, cannabinoids and more. It’s open to the public, industry and more. Register soon!
Regulatory
FDA Guidance: Providing Regulatory Submissions for Promotional Labeling and Advertising Materials
Final guidance includes seven examples of appropriately submitted promotional materials, including video games, exhibit booth banners, and kit materials.
Regulatory
Cosmetics Claims: Stay In Your Lane
Claims to alter one’s appearance are OK, but cosmetics that claim effect on structure or function the body are, legally, drugs.
